Overview

Brain Protection Effect of Selective Head Cooling and Dexmedetomidine in Patients Undergoing Liver Transplantation

Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
0
Participant gender:
All
Summary
The investigators investigated in the present study whether selective head cooling and dexmedetomidine has an effect on cerebral oxygenation during liver transplantation and has cerebral protective effect in patients undergoing liver transplantation.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Huazhong University of Science and Technology
Treatments:
Dexmedetomidine
Criteria
Inclusion Criteria:

- Scheduled for OLT, selected from the Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, China.

- Sign the informed consent

Exclusion Criteria:

- The patients with a history of neurological or psychiatric disorders which impair
cognitive processes, including previously established de-mentia, stroke, schizophrenia
and depression were excluded from the study.

- Patients diagnosed with hepatic encephalopathy or had a low Mini-Mental State
Examination (MMSE) score (below 24) preoperatively.

- With concurrent diseases such as renal insufficiency, diabetes mellitus were also
excluded.

- Patients were excluded if severe reperfusion syn-drome (mean arterial pressure below
60mmHg sustained over 15minutes) occurred perioperatively.